Literature DB >> 32646898

Complete Genome Sequence of Clostridium innocuum Strain LC-LUMC-CI-001, Isolated from a Patient with Recurrent Antibiotic-Associated Diarrhea.

K E Cherny1,2, E A Ozer2, T J Kochan2, S Johnson3, L K Kociolek4,2.   

Abstract

Here, we report the complete genome sequence of Clostridium innocuum strain LC-LUMC-CI-001. As recently as 2018, C. innocuum was generally considered a benign gastrointestinal microorganism. This strain was isolated from the stool of a patient with recurrent Clostridioides difficile infection-like illnesses.
Copyright © 2020 Cherny et al.

Entities:  

Year:  2020        PMID: 32646898     DOI: 10.1128/MRA.00365-20

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


  4 in total

1.  Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies.

Authors:  K E Cherny; A Balaji; J Mukherjee; Y A Goo; A R Hauser; E Ozer; K J F Satchell; K E R Bachta; T J Kochan; S D Mitra; L K Kociolek
Journal:  Anaerobe       Date:  2022-03-31       Impact factor: 2.837

2.  Case-Control Study of Clostridium innocuum Infection, Taiwan.

Authors:  Yi-Ching Chen; Yi-Chun Kuo; Mi-Chi Chen; Young-Da Zhang; Chyi-Liang Chen; Puo-Hsien Le; Cheng-Hsun Chiu
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

3.  Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates.

Authors:  Travis J Kochan; Sophia H Nozick; Rachel L Medernach; Bettina H Cheung; Samuel W M Gatesy; Marine Lebrun-Corbin; Sumitra D Mitra; Natalia Khalatyan; Fiorella Krapp; Chao Qi; Egon A Ozer; Alan R Hauser
Journal:  BMC Infect Dis       Date:  2022-07-07       Impact factor: 3.667

Review 4.  Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen.

Authors:  Kathryn E Cherny; Emily B Muscat; Megan E Reyna; Larry K Kociolek
Journal:  Anaerobe       Date:  2021-07-28       Impact factor: 3.331

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.